SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
璃光浮月
Lv1
20 积分
2020-12-06 加入
最近求助
最近应助
互助留言
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers
2天前
已完结
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia
2天前
已完结
A commentary on “Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials” (Int J Surg. 2024 May 3.)
9天前
已完结
A commentary on “Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T cell - Fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning” (Int J Surg. 2024 May 17.)
9天前
已完结
Clinical characteristics and treatment outcomes of Asian patients with T-cell large granular lymphocytic Leukemia: a single-center analysis of 67 cases
17天前
已完结
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
1个月前
已完结
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
2个月前
已完结
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
2个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
3个月前
已完结
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
3个月前
已完结
没有进行任何应助
点赞,速度真快
2个月前
感谢,点赞,速度真快,帮大忙了
5个月前
感谢,点赞,速度真快
5个月前
感谢,点赞,速度真快
5个月前
感谢,点赞,速度真快
5个月前
感谢感谢
5个月前
感谢感谢,,速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论